RESUMO
Resumo Objetivo Identificar se há diferença na concentração plasmática e eritrocitária de zinco na pessoa idosa com e sem a doença de Alzheimer. Métodos Estudo transversal com grupo comparação, realizado com pessoas idosas com e sem doença de Alzheimer, pareadas por sexo, escolaridade e idade. A concentração de zinco foi medida através de espectrofotometria de absorção atômica em forno grafite. Resultados Total de 102 pessoas, 68 no grupo saudável (NDA-g) e 34 o grupo com doença (DA-g). O grupo DA-g apresentou menores concentrações plasmáticas e maior frequência no primeiro quartil para concentrações intraeritrocitárias de zinco. As concentrações plasmáticas e eritrocitárias não apresentaram correlação com tempo de diagnóstico e a idade em ambos os grupos. Na análise de regressão logística, a concentração plasmática esteve associada à DA-g (OR=0,964; p=0,028). Conclusão Pessoas idosas com doença de Alzheimer apresentam menores concentrações plasmáticas e eritrocitárias de zinco.
Abstract Objective To identify whether there is a difference in plasma and erythrocyte zinc concentration in older adults with and without Alzheimer's disease. Methods Crosssectional study with a comparative group, conducted with older adults with and without Alzheimer's disease, matched by sex, education, and age. Zinc concentration was measured by atomic absorption spectrophotometry in a graphite furnace. Results There were 102 people, 68 in the healthy group (NDA-g) and 34 in the group with disease (AD-g). The AD-g group had lower plasma zinc concentrations and higher frequency in the first quartile for intraerythrocyte zinc concentrations. Plasma and erythrocyte concentrations did not correlate with the time of diagnosis and age in both groups. In the logistic regression analysis, plasma concentration was associated with AD-g (OR=0.964; p=0.028). Conclusion Older people with Alzheimer's disease have lower plasma and erythrocyte zinc concentrations.
RESUMO
The consumption of the regional basic diet (RBD) determines a state of malnutrition found in the low-income population of Northeastern Brazil. A dietary supplement known as multimixture has been used as an alternative source of iron in food for the prevention and/or treatment of anemia and for the recovery from malnutrition. The purpose of the present work was to evaluate the bioavailability of iron in the RBD supplemented with multimixture in iron-depleted and non-depleted Wistar rats. To produce iron depletion in the animals, pretest depletion diets without iron and the pretest control diet based on the AIN-93 diet were used for 8 weeks. This phase was followed by the test diets: control, AIN-93 extrinsically labeled with (59)FeCl(3); RBD, containing carioca beans intrinsically labeled with (59)Fe; and RBDMM, RBD plus multimixture, supplied in a single meal. Hemoglobin concentration, weight gain, and dietary intake were determined in the pretest phase. Iron bioavailability was determined by the determination of total-body radiation in the animals for 7 days, using a solid scintillation detector. The hemoglobin concentration, weight gain, and dietary intake were greater in the non-depleted animals than in the iron-depleted ones. The iron bioavailability of the diets did not differ significantly. It was concluded that the multimixture did not affect the bioavailability of Fe contained in the beans of the RBD.
